Docetaxel Injection Recalled Due to Particulate Matter in Stopper
Sagent Pharmaceuticals is recalling Docetaxel Injection due to particulate matter from the vial stopper. Lot F1040001 was distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall. Per the severity rubric, FDA Class I recalls warrant a minimum severity score of 4 (Severe), regardless of whether illnesses have been reported. No illnesses or injuries are documented in the source.
Plain-English summary
Sagent Pharmaceuticals is recalling Docetaxel Injection, USP (80 mg per 8 mL) due to the presence of particulate matter from the vial stopper. The affected lot is F1040001 (expiration date 12/31/2024), comprising 762 vials that were distributed nationwide.
Docetaxel is a chemotherapy drug administered by intravenous injection. Patients who received doses from this lot should inform their healthcare provider of the recall.
Healthcare facilities with inventory from lot F1040001 should stop dispensing and contact the FDA for guidance on returning the product.
The recalled product
- Product
- DOCETAXEL (DOCETAXEL ANHYDROUS)
- Brand
- DOCETAXEL
- Manufacturer
- Sagent Pharmaceuticals
- Category
- Drug — Injectable / Chemotherapy
- Hazard
- Affected units
- 762
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: F1040001
- Exp. Date 12/31/2024
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Sagent Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · DOCETAXEL
- CriticalDocetaxel Injection Recalled Nationwide for Stopper Particulate Matter
FDA (Drugs) · 2024-06-19
- SevereDr. Reddy's Recalls Docetaxel Injection Due to Vial Seal and Cap Defects
FDA (Drugs) · 2019-03-20
- SevereSanofi Recalls Over-Concentrated Docetaxel Injection Vials Nationwide
FDA (Drugs) · 2018-05-09
- ModerateDr. Reddy's Recalls Docetaxel Injection Vials Due to Seal Defects
FDA (Drugs) · 2018-01-17
Same manufacturer · Sagent Pharmaceuticals
See all →- LowBusulfan Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-05-27
- HighPrescription Corticosteroid Injectable Recalled for Particulate Matter
FDA (Drugs) · 2024-05-22
- HighOxacillin for Injection Recalled Nationwide for Lack of Sterility Assurance
FDA (Drugs) · 2023-08-02
- HighOxacillin Injectable Recalled for Failure to Assure Sterility
FDA (Drugs) · 2023-08-02
- HighOxacillin for Injection recalled nationwide due to sterility concerns
FDA (Drugs) · 2023-08-02
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Tralement Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26